Heisterberg, Jens (2021) How Should Synthetic Follow-Ons of Biological Products Be Regulated? What Are the Implications for Automatic Substitution? ACTA PHARMACEUTICA HUNGARICA, 91 (3-4). pp. 108-109. ISSN 0001-6659
|
Text
60-Article Text-1313-1-10-20220417.pdf Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) | Preview |
Official URL: https://doi.org/10.33892/aph.2021.91.108-109
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine / orvostudomány > RM Therapeutics. Pharmacology / terápia, gyógyszertan |
| SWORD Depositor: | MTMT SWORD |
| Depositing User: | Zsolt Baráth |
| Date Deposited: | 13 May 2022 09:50 |
| Last Modified: | 13 May 2022 09:50 |
| URI: | http://real.mtak.hu/id/eprint/142750 |
Actions (login required)
 |
Edit Item |
